ENDRA Life Sciences (NDRA) SEC Filings: History & Chart

ENDRA Life Sciences Inc.(NDRA)

Medical - Diagnostics & Research · Ann Arbor, MI

$6.04-0.27 (-4.28%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

Ann Arbor, MI

10 employees

www.endrainc.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Alexander Y. Tokman

View full financials

Form	Filing Date	Accepted	Document
S-4	Oct 2, 2026	Oct 1, 2026	View filing
425	Oct 1, 2026	Oct 1, 2026	View filing
8-K	Oct 1, 2026	Oct 1, 2026	View filing
425	Sep 25, 2026	Sep 25, 2026	View filing
425	Sep 14, 2026	Sep 14, 2026	View filing
425	Sep 9, 2026	Sep 9, 2026	View filing
425	Sep 9, 2026	Sep 9, 2026	View filing
425	Aug 21, 2026	Aug 20, 2026	View filing
425	Aug 20, 2026	Aug 20, 2026	View filing
425	Aug 17, 2026	Aug 17, 2026	View filing
8-K	Aug 17, 2026	Aug 17, 2026	View filing
10-Q	Aug 14, 2026	Aug 14, 2026	View filing
425	Aug 6, 2026	Aug 6, 2026	View filing
425	Aug 5, 2026	Aug 5, 2026	View filing
425	Aug 4, 2026	Aug 4, 2026	View filing
425	Jul 22, 2026	Jul 22, 2026	View filing
425	Jul 22, 2026	Jul 22, 2026	View filing
425	Jul 17, 2026	Jul 17, 2026	View filing
425	Jul 17, 2026	Jul 17, 2026	View filing
8-K	Jul 9, 2026	Jul 9, 2026	View filing
SC 13D/A	Jun 29, 2026	Jun 29, 2026	View filing
425	Jun 26, 2026	Jun 26, 2026	View filing
8-K	Jun 26, 2026	Jun 26, 2026	View filing
425	Jun 25, 2026	Jun 25, 2026	View filing
425	Jun 25, 2026	Jun 25, 2026	View filing
8-K	Jun 25, 2026	Jun 25, 2026	View filing
8-K	May 28, 2026	May 28, 2026	View filing
RW	May 26, 2026	May 26, 2026	View filing
S-8	May 15, 2026	May 15, 2026	View filing
10-Q	May 15, 2026	May 15, 2026	View filing

SEC Filings

Recent Filings